PCSK9-D374Y mediated LDL-R degradation can be functionally inhibited by EGF-A and truncated EGF-A peptides: An in vitro study-论文-万方医学网

PCSK9-D374Y mediated LDL-R degradation can be functionally inhibited by EGF-A and truncated EGF-A peptides: An in vitro study

导出原文传递

翻译打印收藏纠错

作者： Valenti, Vincenza ^[1] ; Noto, Davide ; Giammanco, Antonina ; Fayer, Francesca ; Spina, Rossella ; Altieri, Grazia, I ; Ingrassia, Valeria ; Scrimali, Chiara ; Barbagallo, Carlo M. ; Brucato, Federica ; Misiano, Gabriella ; Cefalu, Angelo B. ; Averna, Maurizio R.

作者单位： Univ Palermo,Univ Palermo, Dipartimento Promoz Salute Materno Infantile Med, Via Vespro 129, I ^[1]

关键词 PCSK9 PCSK9 inhibition LDLR EGF-A domain Small peptides Decoy strategy AUTOSOMAL-DOMINANT HYPERCHOLESTEROLEMIA DENSITY-LIPOPROTEIN LDL SUBTILISIN/KEXIN TYPE 9 SECRETED PCSK9 FAMILIAL HYPERCHOLESTEROLEMIA RECEPTOR MUTATIONS CHOLESTEROL EXPRESSION BINDING

发布时间 2022-10-29

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

PCSK9-D374Y mediated LDL-R degradation can be functionally inhibited by EGF-A and truncated EGF-A peptides: An in vitro study

相似文献

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

PCSK9-D374Y mediated LDL-R degradation can be functionally inhibited by EGF-A and truncated EGF-A peptides: An in vitro study

相似文献

相关期刊

检索历史清除